+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biocompatibility Testing Market by Test Type, End-Use Application, Material Type, Technique, Testing Standard, Service Provider - Global Forecast to 2030- Product Image
Biocompatibility Testing Market by Test Type, End-Use Application, Material Type, Technique, Testing Standard, Service Provider - Global Forecast to 2030- Product Image
Sale

Biocompatibility Testing Market by Test Type, End-Use Application, Material Type, Technique, Testing Standard, Service Provider - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015208
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biocompatibility testing market is evolving as new materials, regulatory changes, and technology advancements drive more rigorous safety assessments for medical devices. Senior decision-makers require current, actionable insights to anticipate regulatory shifts, optimize testing operations, and capitalize on industry growth opportunities.

Market Snapshot: Biocompatibility Testing Market Trends

The biocompatibility testing market grew from USD 3.13 billion in 2024 to USD 3.42 billion in 2025. Sustained demand for advanced medical devices across cardiovascular, orthopedic, and specialized therapeutic areas underpins robust market momentum. The sector is forecasted to maintain a compound annual growth rate of 9.09% over the next five years, ultimately reaching USD 5.29 billion by 2030. This trajectory reflects both expanding regulatory scrutiny and heightened adoption of next-generation testing methodologies to accelerate device commercialization and uphold patient safety standards.

Scope & Segmentation

  • Test Types: Cytotoxicity (agar diffusion, elution test, MTT assay), genotoxicity, hemocompatibility, irritation, pyrogenicity, sensitization.
  • End-Use Applications: Cardiovascular devices, dental devices, ophthalmic devices, orthopedic implants, wound care.
  • Material Types: Ceramics, composites, elastomers, metals, polymers.
  • Techniques: Analytical (chromatography, microscopy, spectroscopy), computational modeling, in vitro testing, in vivo testing.
  • Testing Standards: ASTM standards, ISO 10993, USP standards.
  • Service Providers: Academic institutions, contract research organizations, in house facilities, testing laboratories.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, and Taiwan).
  • Leading Companies Profiled: Eurofins Scientific SE, SGS SA, Intertek Group plc, Bureau Veritas SA, TÜV SÜD AG, TÜV Rheinland AG, Nelson Laboratories, Charles River Laboratories International, Covance Inc., WuXi AppTec Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Increasing complexity in device materials, such as composites and specialty polymers, is prompting demand for advanced analytical and in vitro testing protocols tailored to modern application needs.
  • Integration of computational modeling with conventional testing is reducing reliance on animal models, cutting costs, and expediting product timelines for manufacturers seeking regulatory compliance.
  • Regulatory convergence and the expansion of ISO 10993 and ASTM standards are facilitating streamlined global submissions, reducing approval bottlenecks while ensuring consistency in safety assessment practices.
  • Collaboration between academic institutions, contract research organizations, and in-house teams is fostering method innovation, accelerating early-stage validation, and expanding capacity for high-volume testing demands.
  • Service providers are refining their portfolios to include trace-level impurity detection using next-generation chromatography and enhanced analytical platforms, strengthening product safety dossiers.

Tariff Impact on Testing Operations

Recently imposed United States tariffs on critical raw materials, including metallic alloys and polymers, are driving up costs across the supply chain for both manufacturers and testing laboratories. These levies are particularly affecting sample preparation expenses and procurement of high-grade analytical reagents, prompting sector-wide pricing adjustments and operational recalibrations. To mitigate these pressures, organizations are exploring batch processing efficiencies, negotiation of bulk import agreements, and the development of nearshore partnerships to maintain testing rigor and operational resilience.

Methodology & Data Sources

This report is grounded in comprehensive secondary research from regulatory databases, peer-reviewed journals, standards body publications, and industry whitepapers. It is enhanced by targeted primary interviews with toxicologists, laboratory leaders, and materials experts. Data validation uses a qualitative and quantitative triangulation approach to assure robust, reliable market insight.

Why This Report Matters

  • Enables leaders to benchmark current biocompatibility testing practices and anticipate evolving regulatory requirements impacting global device development.
  • Supports strategic investment through segmentation clarity, highlighting fastest-growth test categories, materials, and emerging regional hubs.
  • Delivers evidence-based guidance for mitigating external pressures, such as tariffs, while maintaining testing quality and market competitiveness.

Conclusion

This research delivers targeted intelligence for navigating shifts in biocompatibility testing. Decision-makers equipped with these insights can strategically adapt, optimize resources, and maintain a competitive edge in a dynamic regulatory environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biocompatibility Testing Market, by Test Type
8.1. Introduction
8.2. Cytotoxicity
8.2.1. Agar Diffusion
8.2.2. Elution Test
8.2.3. Mtt Assay
8.3. Genotoxicity
8.4. Hemocompatibility
8.5. Irritation
8.6. Pyrogenicity
8.7. Sensitization
9. Biocompatibility Testing Market, by End-Use Application
9.1. Introduction
9.2. Cardiovascular Devices
9.3. Dental Devices
9.4. Ophthalmic Devices
9.5. Orthopedic Implants
9.6. Wound Care
10. Biocompatibility Testing Market, by Material Type
10.1. Introduction
10.2. Ceramics
10.3. Composites
10.4. Elastomers
10.5. Metals
10.6. Polymers
11. Biocompatibility Testing Market, by Technique
11.1. Introduction
11.2. Analytical Techniques
11.2.1. Chromatography
11.2.2. Microscopy
11.2.3. Spectroscopy
11.3. Computational Modeling
11.4. In Vitro Testing
11.5. In Vivo Testing
12. Biocompatibility Testing Market, by Testing Standard
12.1. Introduction
12.2. Astm Standards
12.3. Iso 10993
12.4. Usp Standards
13. Biocompatibility Testing Market, by Service Provider
13.1. Introduction
13.2. Academic Institutions
13.3. Contract Research Organizations
13.4. In House Facilities
13.5. Testing Laboratories
14. Americas Biocompatibility Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biocompatibility Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biocompatibility Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Eurofins Scientific SE
17.3.2. SGS SA
17.3.3. Intertek Group plc
17.3.4. Bureau Veritas SA
17.3.5. TÜV SÜD AG
17.3.6. TÜV Rheinland AG
17.3.7. Nelson Laboratories, LLC
17.3.8. Charles River Laboratories International, Inc.
17.3.9. Covance Inc.
17.3.10. WuXi AppTec Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOCOMPATIBILITY TESTING MARKET MULTI-CURRENCY
FIGURE 2. BIOCOMPATIBILITY TESTING MARKET MULTI-LANGUAGE
FIGURE 3. BIOCOMPATIBILITY TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOCOMPATIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOCOMPATIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOCOMPATIBILITY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY AGAR DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ELUTION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MTT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY GENOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY HEMOCOMPATIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY IRRITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY PYROGENICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SENSITIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY DENTAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY OPHTHALMIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CERAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ELASTOMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY METALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COMPUTATIONAL MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY IN VIVO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ASTM STANDARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ISO 10993, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY USP STANDARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY IN HOUSE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 67. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 70. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 71. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 72. CANADA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 75. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 114. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 115. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 116. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 120. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 121. GERMANY BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 124. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 128. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 129. FRANCE BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 138. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 140. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 143. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 144. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 145. ITALY BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 146. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 147. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 148. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 150. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 151. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 152. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 153. SPAIN BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 178. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 180. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 182. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 183. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 184. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 185. DENMARK BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 194. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 195. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 196. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 198. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 199. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 200. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 201. QATAR BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 202. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 203. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 204. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 206. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 207. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 208. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 209. FINLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 222. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 223. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 224. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 225. NIGERIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 226. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 227. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 228. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 230. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 231. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 232. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 233. EGYPT BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 234. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 235. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 236. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 239. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 240. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 241. TURKEY BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 250. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 251. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 252. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 254. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 255. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 256. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 257. NORWAY BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 258. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 259. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 260. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 262. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 263. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 264. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 265. POLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 273. SWITZERLAND BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 283. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 284. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 285. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 287. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 288. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 289. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 290. CHINA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 291. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 292. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 293. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 296. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 297. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 298. INDIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 299. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 300. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 301. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 303. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 304. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 305. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 306. JAPAN BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 314. AUSTRALIA BIOCOMPATIBILITY TESTING MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY CYTOTOXICITY, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY ANALYTICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 321. SOUTH KOREA BIOCOMPATIBILITY TESTING MARKET SIZE, BY TESTING STANDARD, 2018-2030 (USD MILLION)
TABLE 322.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biocompatibility Testing market report include:
  • Eurofins Scientific SE
  • SGS SA
  • Intertek Group plc
  • Bureau Veritas SA
  • TÜV SÜD AG
  • TÜV Rheinland AG
  • Nelson Laboratories, LLC
  • Charles River Laboratories International, Inc.
  • Covance Inc.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.29 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bioceramics Market Report by Material, Biocompatibility, Application, and Region 2025-2033 - Product Image

Bioceramics Market Report by Material, Biocompatibility, Application, and Region 2025-2033

  • Report
  • 147 Pages
  • Global
From
Spinal Implant Testing Service Market by Test Type, Product Type, End User, Material Type, Testing Method - Global Forecast to 2030 - Product Image

Spinal Implant Testing Service Market by Test Type, Product Type, End User, Material Type, Testing Method - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Biocompatibility Protocols for Medical Devices and Materials - Product Image

Biocompatibility Protocols for Medical Devices and Materials

  • Book
Biocompatibility and Performance of Medical Devices - Product Image

Biocompatibility and Performance of Medical Devices

  • Book
  • 540 Pages
Biocompatible Coatings Market by Material Type, Application, End User Industry, Technology - Global Forecast to 2030 - Product Image

Biocompatible Coatings Market by Material Type, Application, End User Industry, Technology - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.